Celcuity Inc. (CELC): Total Assets
$466.56M
As of 2025-12-31
$828.22M
As of 2026-06-30
+38.5%
3-year compound annual growth
+104.8%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $466.56M | +90.3% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $245.12M | +28.2% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $191.22M | +8.8% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $175.70M | +104.5% | 2024-03-27, Balance as of period end |
| 2021-12-31 | $85.91M | +563.0% | 2023-03-23, Balance as of period end |
| 2020-12-31 | $12.96M | -36.1% | 2022-03-23, Balance as of period end |
| 2019-12-31 | $20.28M | -22.1% | 2021-02-16, Balance as of period end |
| 2018-12-31 | $26.03M | -18.6% | 2020-03-13, Balance as of period end |
| 2017-12-31 | $31.97M | +427.8% | 2019-03-01, Balance as of period end |
| 2016-12-31 | $6.06M | n/a | 2018-03-15, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Celcuity Inc. (CELC) | 2025-12-31 | $466.56M | +90.3% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $413.23M | -15.8% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $578.56M | +8.9% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $632.65M | +109.4% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $334.16M | +23.6% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $1.13B | +227.5% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $1.21B | -0.5% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $1.41B | +8.2% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $2.01B | +35.5% |
Compare CELC, CDNA, CSTL, BLLN side by side · Screen every company in Services-Medical Laboratories ↗